Evaluating mitotic activity in canine and feline solid tumors: standardizing the parameter.

Area of Science:

• Veterinary Pathology
• Oncology
• Histopathology

Background:

• Accurate assessment of tumor cell proliferation is crucial for diagnosis and prognosis in veterinary oncology.
• Existing methods for evaluating mitotic activity in canine and feline tumors vary in objectivity and correlation with other proliferation markers.

Purpose of the Study:

• To compare three methods of assessing mitotic activity (mitotic count, mitoses/area, mitotic index) in canine and feline solid tumors.
• To determine which method is most objective and best correlates with other cell proliferation parameters.
• To evaluate the ability of each method to discriminate tumor groups based on histological criteria.

Main Methods:

• Toluidine blue stained histological sections of canine and feline solid tumors were used.
• Mitotic activity was quantified using an image analyzer.
• Comparison with histochemical (AgNOR proteins) and immunohistochemical (MIB1, PCNA) markers of cell proliferation was performed.
• Linear regression analysis was used to assess correlations between methods.

Main Results:

• The mitotic index showed a 1000% correlation with other cell proliferation parameters.
• Mitoses/area and mitotic count demonstrated a 40% correlation with other proliferation parameters.
• Mitotic index and mitotic count achieved 1000% concordance in discriminating tumor proliferative activity based on histological criteria.
• Mitoses/area showed 80% concordance in discriminating tumor proliferative activity.

Conclusions:

• The mitotic index is the most reliable and objective method for assessing cell proliferation in canine and feline tumors.
• Mitotic index and mitotic count are superior to mitoses/area for discriminating tumor proliferative activity and correlating with other proliferation markers.
• Standardizing mitotic activity assessment using the mitotic index can improve diagnostic accuracy in veterinary oncology.